Ken Page
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
-
- Computational Drug Discovery Methods
Papers in
-
- Protease and Inhibitor Mechanisms 7
-
- Drug-Induced Hepatotoxicity and Protection 2
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Richard John Weaver (2 shared papers)Lars O. G. Weidolf (2 shared papers)Richard A. Thompson (2 shared papers)Yan Li (2 shared papers)J. Gerry Kenna (2 shared papers)Hugues Dolgos (2 shared papers)Emre Mehmet Isin (2 shared papers)Ian D. Wilson (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (13 papers)Journal of Medicinal Chemistry (5 papers)Sensors and Actuators B Chemical (2 papers)Chemico-Biological Interactions (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Ken Page
25 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 85
- Pharmacology 215
- Computational Theory and Mathematics 185
- Organic Chemistry 324
- Cancer Research 120
- Molecular Biology 560
Countries citing papers authored by Ken Page
This map shows the geographic impact of Ken Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Page more than expected).
Fields of papers citing papers by Ken Page
This network shows the impact of papers produced by Ken Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Page. The network helps show where Ken Page may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Page, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 419 | |
| 2 | 2013 | 203 | |
| 3 | 2013 | 195 | |
| 4 | 2012 | 177 | |
| 5 | 2003 | 142 | |
| 6 | 2010 | 81 | |
| 7 | 2015 | 54 | |
| 8 | 2004 | 43 | |
| 9 | 2012 | 36 | |
| 10 | 2015 | 33 | |
| 11 | 2008 | 24 | |
| 12 | 2012 | 20 | |
| 13 | 2013 | 20 | |
| 14 | 1998 | 19 | |
| 15 | 2015 | 17 | |
| 16 | 2011 | 15 | |
| 17 | 2009 | 13 | |
| 18 | 2011 | 13 | |
| 19 | 1998 | 12 | |
| 20 | 2009 | 12 |
About Ken Page
Ken Page is a scholar working on Cancer Research, Pharmacology, Molecular Biology, Organic Chemistry and Computational Theory and Mathematics, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Synthesis and biological activity (3 papers), Phosphodiesterase function and regulation (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Computational Drug Discovery Methods (2 papers) and Clinical Laboratory Practices and Quality Control (1 paper). The work is most often cited by research in Pharmacology (215 citations), Computational Theory and Mathematics (185 citations), Organic Chemistry (324 citations), Cancer Research (120 citations) and Molecular Biology (560 citations). Ken Page has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Richard John Weaver, Lars O. G. Weidolf, Richard A. Thompson, Yan Li, J. Gerry Kenna, Hugues Dolgos, Emre Mehmet Isin, Ian D. Wilson, Brian J. Middleton and Steve Swallow. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Sensors and Actuators B Chemical, Chemico-Biological Interactions and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.